Main Page
 
Sponsors











Selçuk Ecza Deposu














Marmara University, Faculty of Pharmacy,
Alumni Association
 
Poster

 
Scientific Secretariat


İlkay KÜÇÜKGÜZEL
Marmara University Faculty of Pharmacy

Phone: +90 216 349 12 16
E-Mail: ikucukguzel@marmara.edu.tr
Web: www.pharmacy.marmara.edu.tr


Organization Secretariat

TOPKON CONGRESS SERVICES
Zühtüpaşa Mah. Rıfatbey Sok.
No:24 Kadıköy 34724 İstanbul
Phone: +90 216 330 90 20 (pbx)
Fax: +90 216 330 90 05-08
E-mail: impps3@topkon.com
Web: www.topkon.com




Untitled Document

SCIENTIFIC PROGRAM

WEDNESDAY, JUNE 09 THURSDAY, JUNE 10 FRIDAY, JUNE 11 SATURDAY, JUNE 12


WEDNESDAY, JUNE 09

13.00-16.30

REGISTRATION

Hall 1
SESSION I
Inaugural Lecture

16.30-17.30

OPENING CEREMONY

Chairperson

İlkay Küçükgüzel (Marmara University, Turkey)

17.30-18.30
PL-1

The antiviral drug era: Half a century after the synthesis of the first antiviral drug
Erik De Clercq (Rega Institute, Katholieke Universiteit Leuven, Belgium)

18.30-21.00

WELCOME RECEPTION

THURSDAY, JUNE 10

HALL 1
SESSION II
Computational chemistry & molecular modeling
HALL 2
SESSION III
Natural products & phytotheraphy
Chairpersons : Sumru Özkırımlı(Istanbul University, Turkey)
Salvatore Guccione (Catania University)
Chairpersons : Filiz Meriçli (İstanbul University, Turkey)

09.00-09.40
PL-2

Computer aided drug design studies on chemotherapeutically active heterocyclic compounds
Esin Akı (Ankara University, Turkey)

09.00-09.40
PL-4

Scientific evaluation of Turkish folk remedies for wound healing
Erdem Yeşilada (Yeditepe University, Turkey)

09.40-10.20
PL-3

De novo design of selective monoamine oxidase A and B inhibitors : evaluation of  novel pyrazoline  derivatives using molecular modeling techniques
Kemal Yelekçi (Kadir Has University, Turkey)

09.40-10.20
PL-5

Developing herbal medicines: Can metabolomic approaches help in establishing their quality and safety?
Michael Heinrich (University of London, UK)

10.20-10.40

COFFEE BREAK & EXHIBITION

HALL 1
SESSION IV
Drug delivery & drug targeting
HALL 2
SESSION V
Drug safety & personalized medicine
Chairpersons : Atilla Hıncal (Hacettepe University, Turkey)
Elizabeth Colbourn (Intelligensys Ltd., UK)
Chairpersons : Gül Dülger  (Marmara University, Turkey)
Véronique Michaud (Montréal University, Canada)

10.40-11.20
PL-6

Peptide drug delivery using phospholipid nanomicelles
Hayat Önyüksel (University of Illinois, USA)

10.40-11.20
PL-9

The metabolomics revolution in drug metabolism
Jeffrey R. Idle (Charles University, Czech Republic)

11.20-12.00
PL-7

Advances responsive and feedback-controlled nanoparticles for drug and protein delivery
Nicholas Peppas (University of Texas, USA)

11.20-12.00
PL-10

Pharmacogenetics/genomics for predictiveand personalized medicine in post genomic era
Candan Hızel (Centre Jean Perrin Anti-cancereux-Clermont-frerand, France)

12.00-12.40
PL-8

Brain drug targeting
Yılmaz Çapan (Hacettepe University, Turkey)

12.40-14.00

LUNCH

13.00-15.00

PROF.DR. MUSTAFA NEVZAT PISAK HALL
Workshop on Pharmaceutical Care in Diabetes
Fikret Vehbi İzzettin, Mesut Sancar, Şule Rabuş, Betül Okuyan

HALL 1
SESSION VI
Proteins & peptidomimetics for future drugs
HALL 2
SESSION VII
Pharmacogenetics & cardiovascular disease
Chairpersons : Güler Yalçın   (Marmara University, Turkey),
İsmail Yalçın (Ankara University, Turkey)
Chairpersons : Semra Şardaş (Marmara University, Turkey),
Jeffrey R. Idle (Charles University, Czech Republic)

14.00-14.40
PL-11

Translating information about biochemical pathways into practical, small organic or peptidomimetic therapeutic agents
Salvatore Guccione (Catania University, Italy)

14.00-14.40
PL-14

Pharmacogenetics and cardiovascular drugs
Jacques Turgeon(Montréal University, Canada)

14.40-15.20
PL-12

Potential protein drugs: New protein K dependent proteins and their receptors
Fikriye Uras (Marmara University, Turkey)

14.40-15.20
PL-15

The influence of pharmacogenetics for warfarine dose requirements
Véronique Michaud (Montréal University, Canada)

15.20-16.00
PL-13

Understanding protein properties: essential for proteomics, quality control, binding assays and molecular modelling
Hermann Wätzig (Technical University Braunschweig, Germany)

15.20-16.00   
OP-1

Resistin gene expression in type 2 diabetic patients human adipose tissues: relationship with drug use: relationship with drug use
Belgin Süsleyici Duman (Marmara University, Turkey)

PROF.DR. MUSTAFA NEVZAT PISAK HALL
Clinical parmacy and pharmaceutical care

Chairperson: Levent Kabasakal (Marmara University, Turkey)

15.00-15.20
OP-2

The effect of medication compliance on control of chronic diseases
Feras Jassim Jirjees (Sharjah University, UAE)

15.20-15.40
OP-3

Old and new antiarrythmics medications: Current directions
Muneera Albabtain (Prince Sultan Cardiac Center, Saudi Arabia)

15.40-16.00
OP-4

Cardiac rehabilitation: Measures and tools
Fadwa Fadwa   (Prince Sultan Cardiac Center, Saudi Arabia)

Chairperson: Azize Şener (Marmara University, Turkey)

16.20-16.40
OP-5

Some tacrolimus pharmacokinetic properties in Iranian liver transplant recipients.
Simin Dashti - Khavidaki  (Tehran University of Medical Sciences, Iran)

16.40-17.00
OP-6

Enhancement of the cytotoxicity of anticancer drugs by celecoxib is cell type-, drug- and sequence-dependent.
Raafat El-Awady (Sharjah University, UAE)

16.00-16.20

COFFEE BREAK & EXHIBITION

HALL 1
SESSION VIII
The use of ANN in pharmacy research
HALL 2
SESSION IX
Rational pharmacotherapy teaching in Turkey
Chairperson : Betül Dortunç (Marmara University, Turkey) Chairperson : Berrak Yeğen (Marmara University, Turkey)

16.20-17.00
PL-16

Machine Learning Technologies in Pharmaceutical Formulation
Elisabeth Colbourn (Intelligensys Ltd., UK)

16.20-17.00
PL-17

PL-17a : Problem based Rational Pharmacotherapy Teaching : An Experience in a Medical School in Turkey
Ersin Yarış (Karadeniz Technical University, Turkey)

PL-17b
: Problem based Rational Pharmacotherapy Teaching : An Experience in a Pharmacy School in Turkey
Hale Z. Toklu (Marmara University, Turkey)

FRIDAY, JUNE 11

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION X
Recent developments on antiviral & antituberculosis drug design
HALL 1
SESSION XI
Oxidative damage & antioxidants
Chairperson : Dilek Erol (Yeditepe University, Turkey)
Chairpersons : Göksel Şener (Marmara University, Turkey),
Fikriye Uras (Marmara University, Turkey)

09.00-09.40
PL-18

Inhibitors of hepatitis C virus replication
Neerja Kaushik – Basu
(New Jersey MedicalSchool, USA)

09.00-09.40
PL-20

Melatonin:  mechanisms as an antioxidant and clinical applications
Russel J. Reiter (University of Texas, USA)

09.40-10.20
PL-19

Prevention of HIV by means of microbicide formulations. Why does it take so long?
Paul J. Lewi
(Janssen Pharmaceutica, Belgium)

09.40-10.20
PL-21

The roles of multidrug resistance transporter (Mdr)-1 and multidrug resistance-associated protein (Mrp)-1 in the treatment of stroke
Ertuğrul Kılıç (Yeditepe University, Turkey)

10.20-10.40

COFFEE BREAK & EXHIBITION

10.00-12.00

PROF.DR. MUSTAFA NEVZAT PISAK HALL
Panel on Pharmacoeconomics
Moderator :Erdal Akalın
Speakers : Mehtap Tatar, Aylin Sancar, Ömer Saka, Ali Edizer, Akif Akbulat

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XII
New frontiers on the treatment of neoplastic diseases
HALL 1
SESSION XIII
New approaches for drug formulation
Chairpersons : Rolf W. Hartmann (Saarland University, Germany)
Birsen Tozkoparan
(Hacettepe University, Turkey)
Chairpersons : Gülgün Yener, (İstanbul University, Turkey)
Yılmaz Çapan (Hacettepe University, Turkey)

10.40-11.20
PL-22

New potent inhibitors of human protein kinase CK2, a target in neoplastic diseases
Joachim Jose (Heinrich Heine University)

10.40-11.20
PL-24

Dry powder inhalers: construction of antibiotic microparticles for lung infection treatment
Paolo Colombo (University of Parma, Italy)

11.20-12.00
PL-23

Molecular Targeted Therapies In Cancer Medicine
Emin Kansu (Hacettepe University, Turkey)

11.20-12.00
PL-25

The role of gamma scintigraphy in pharmaceutical product development
Fiona McInnes (University of Strathclyde, UK)

12.00-13.30

LUNCH

13.00-13.30

POSTER SESSION

   
ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XIV
Neuroscience & antipsychotic targets
HALL 1
SESSION XV
Biotechnology and Nanotechnology
Chairpersons : Kemal Yelekçi (Kadir Has University, Turkey) Chairpersons : Jülide Akbuğa (Marmara University, Turkey)
Ahmet Zeki Şengil (Marmara University, Turkey)

13.30-14.10
PL-26

Novel enzymatic pathways in Alzheimer's disease pathogenesis
Domenico Praticò (Temple University, USA)

13.30-14.10
PL-29

Functional macromolecules for drug delivery
Rana Sanyal (Boğaziçi University, Turkey)

14.10-14.50
PL-27

Glutamatergic system and its role in neurobiology of psychiatric disorders
Feyza Arıcıoğlu(Marmara University, Turkey)

14.10-14.50
PL-30

An old material for new applications: Carbon nanotube carriers for drug delivery
İ.Tuncer Değim  (Gazi University, Turkey)

14.50-15.30
PL-28

Design and synthesis of selective glutamate receptor agonists
Rasmus P. Clausen (University of Copenhagen, Denmark)

14.50-15.30
PL-31

Human tooth germ stem cells (HTGSCs): A promising stem cell source
Fikrettin Şahin(Yeditepe University, Turkey)

15.30-15.50

COFFEE BREAK & EXHIBITION

PROF.DR. MUSTAFA NEVZAT PISAK HALL

Pharmaceutical analysis and formulation
Chairperson : Adnan Aydın (Marmara University, Turkey)
Drug formulation
Chairperson : Paolo Colombo (University of Parma, Italy)

13.30-13.50
OP-7

Development and validation of an HPLC method for the determination of atorvastatin and its impurities.
Serap Odabaşı (Bilim Pharmaceuticals, Turkey)

14.30-14.50
OP-10

Orally fast disintegrating tablets: Developments, technologies and clinical studies
Tansel Çomoğlu (Ankara University, Turkey)

13.50-14.10
OP-8

A stability-indicating UPLC method for the determination of levofloxacin and its related compounds.
İlkay Küçükgüzel (Marmara University, Turkey)

14.50-15.10
OP-11

Preparation and characterization of vascular endothelial growth factor loaded poly(lactic-co-glycolic acid) microspheres
Oya Sipahigil (Marmara University, Turkey)

14.10-14.30
OP-9

A novel accelerated in vitro release method for biodegradable coating of drug eluting stents: Insight to the drug release mechanisms.
Marika Kamberi (Abbott Vascular Inc., USA)

16.10-16.30
OP-12

Formulation of herbal conditioner shampoo and evaluation it’s physicochemical properties.
Gholamreza Dehghan – Noudeh (Kerman University of Medical Sciences, Iran)

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XVI
Drug discovery & development
HALL 1
SESSION XVII
Pharmaceutical care
Chairperson : Rasmus P. Clausen (University of Copenhagen, Denmark) Chairperson : Türkan Yurdun (Marmara University, Turkey)

15.50-16.30
PL-32

From target identifcation, hit discovery to lead optimisation: recent examples from our research
Rolf W. Hartmann (Saarland University, Germany)

15.50-16.30
PL-33

Development of clinical pharmacy and pharmaceutical Care in Turkey
Fikret Vehbi İzzettin (Marmara University, Turkey)

SATURDAY, JUNE 12

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XVIII
Novel approaches for cosmetics

HALL 1
SESSION XIX
Drug metabolism & metabolite-induced toxicity

Chairpersons : Yıldız Özsoy-Erginer (İstanbul University, Turkey)
Ayla Gürsoy (Marmara University, Turkey)

Chairpersons : Jacques Turgeon (Montréal University, Canada)
Feyza Arıcıoğlu (Marmara University, Turkey)

09.00-09.40
PL-34

Usage of nanotechnology and biotechnology in cosmetology
Gülgün Yener (İstanbul University, Turkey)

09.00-09.40
PL-37

Toxicity of Mycotoxins
Gülden Z. Omurtag (Marmara University, Turkey)

09.40-10.20
PL-35

What are the novelties in cosmetic science: expectations and responses
Yasemin Yazan (Anadolu University, Turkey)

09.40-10.20
PL-38

In vitro drug metabolism studies : What have we learned from biotransformation of amines ?
Mert Ülgen (Acıbadem University, Turkey)

10.20-11.00
PL-36

Development of dermal and oral products based on tea extracts
Murat Türkoğlu (Marmara University, Turkey)

10.20-11.00
PL-39

Pharmacogenetics is the important component of pharmacovigilance
Semra Şardaş (Marmara University, Turkey)

11.00-11.20

COFFEE BREAK & EXHIBITION

PROF.DR. MUSTAFA NEVZAT PISAK HALL

Research on Pharmaceutical Chemistry
Chairpersons : Fatma Gümüş - (Gazi University, Turkey)
Safiye Erdem (Marmara University, Turkey)

Rational Drug Design
Chairperson : Esin Akı - (Ankara University, Turkey)
Bedia Kaymakçıoğlu (Marmara University, Turkey)

09.00-09.20
OP-13

Synthesis and AChE/BuChE inhibitory and antimicrobial activities of 6-substituted-3(2H)-pyridazinone-2-propyl-3-(substituted/nonsubstituted benzal) hydrazones
Mehtap Gökçe (Gazi University, Turkey)

10.00-10.20
OP-16

Synthesis and selective inhibitory activity against MAO of 3-substituted benzylidenehydrazine derivatives containing 2-benzoxazolinones and molecular docking studies
Nesrin Gökhan Kelekçi (Hacettepe University, Turkey)

09.20-09.40
OP-14

Synthesis and evaluation of antiviral activity of some novel heterocyclic thiourea compounds
Esra Tatar (Marmara University, Turkey)

10.20-10.40
OP-17

QSAR study of phenylalkylamine derivatives as monoamine oxidase inhibitors
Safiye Erdem (Marmara University, Turkey)

09.40-10.00
OP-15

3,6-Disubstituted 7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines as novel analgesic/anti-inflammatory compounds
Peri Aytaç (Hacettepe University, Turkey)

10.40-11.00
OP-18

Investigation of ligand recognition by beta-lactamases.
Elif Özkırımlı Ölmez (Boğaziçi University, Turkey)

PROF. DR. MUSTAFA NEVZAT PISAK HALL

Diabetes and Cardiovascular Disease
Chairperson:  Mesut Sancar (Marmara University, Turkey)
11.00-11.20
OP-19   

Diabetes Mellitus management and its implication to cardiovascular disease
Muneera Albabtain (Prince Sultan Cardiac Center, Saudi Arabia)

11.20-11.40
OP-20  

Plasma matrix gla protein (mgp) levels in patients with coronary artery disease
Erdem Yılmaz (Marmara University, Turkey)

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XX

HALL 1
SESSION XXI

Chairperson : Emre Dölen (Marmara University, Turkey)

Chairperson : Fikret Vehbi İzzettin (Marmara University Turkey)

11.20-12.00
PL-40

New materials and technologies for separation of chiral drugs
Bezhan Chankvetadze (Tbilisi State University, Georgia)

PL-41

Gender difference in science
Berrak Yeğen (Marmara University, Turkey)

12.00-13.30

LUNCH

13.00-13.30

POSTER SESSION

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
SESSION XXII
Pharmaceutical Industry

HALL 1
SESSION XXIII
Therapeutic applications of immunology

Chairpersons : Fethi Şahin (Gazi University, Turkey) ;
Mert Ülgen (Acıbadem University, Turkey)

Chairpersons : Fikrettin Şahin (Yeditepe University, Turkey)

13.30-14.10
PL-42

Drug discovery and development
Esen Bellur(Zentiva Pharmaceuticals, API Plant, Turkey)

13.30-14.10
PL-44
Allergen specific immunotheraphy in allergic disease
Tunç Akkoç
(Marmara University, Turkey)

14.10-14.50
PL-43

The effects of patent protection in Turkish pharmaceutical industry
Tuncer Arslan(Koçak Pharmaceuticals, Turkey)

   

PROF.DR. MUSTAFA NEVZAT PISAK HALL

New applications for pharmacy and hospital practice
Chairperson : Şule Apikoğlu Rabuş (Marmara University, Turkey)

13.10-13.30
OP-21

Radiopharmacy applications in hospital practice
Mine Silindir (Hacettepe University, Turkey)

13.30-13.50
OP-22

Fat Mass and Obesity Associated Gene Expression in Human Omental and Subctaneous Adipose Tissue
Meliha Koldemir (Marmara University, Turkey)

13.50-14.10
OP-23

Relationship between eNOS Glu298asp Polymorphism in Acute Coronary Syndrome and Coronary Heart Disease Patients.
Belgin Süsleyici Duman (Marmara University, Turkey)

14.10-14.30
OP-24

Assessment of the 5th grade pharmacy students’ opinions on the first-time held ‘Pharmacy Practice I’ course of the second cycle
Betül Okuyan (Marmara University, Turkey)

14.30-14.50
OP-25

Does Phototherapy Cause Dna Damage in Psoriasis Patients ?
Diren Beyoğlu (Marmara University, Turkey)

14.50-15.10

COFFEE BREAK & EXHIBITION

15.10-16.00

ORD.PROF.DR. REŞAT KAYNAR AUDITORIUM
CLOSING CEREMONY

www.verus.com.tr